|
PIAS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.90710000025751E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.420500E-02 |
| Normal-vs-Stage2 |
1.333570E-01 |
| Normal-vs-Stage3 |
4.29109999755539E-08 |
| Normal-vs-Stage4 |
3.38829997392764E-09 |
| Stage1-vs-Stage2 |
6.219400E-01 |
| Stage1-vs-Stage3 |
2.432300E-04 |
| Stage1-vs-Stage4 |
1.5729799999975E-05 |
| Stage2-vs-Stage3 |
4.038400E-02 |
| Stage2-vs-Stage4 |
3.278100E-03 |
| Stage3-vs-Stage4 |
1.378990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.12240000005315E-06 |
| Normal-vs-AfricanAmerican |
1.588470E-02 |
| Normal-vs-Asian |
7.599000E-01 |
| Caucasian-vs-AfricanAmerican |
7.831200E-01 |
| Caucasian-vs-Asian |
6.246000E-01 |
| AfricanAmerican-vs-Asian |
5.995800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.10360000044652E-07 |
| Normal-vs-Female |
2.816000E-03 |
| Male-vs-Female |
2.583000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.008600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.878040E-02 |
| Normal-vs-Age(61-80Yrs) |
4.13479994687549E-09 |
| Normal-vs-Age(81-100Yrs) |
9.366400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.641600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.736000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.147600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.361100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.744800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.777200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.207400E-01 |
| Normal-vs-Grade 2 |
1.684180E-01 |
| Normal-vs-Grade 3 |
1.12000000385137E-08 |
| Normal-vs-Grade 4 |
1.75390000300979E-08 |
| Grade 1-vs-Grade 2 |
9.823200E-01 |
| Grade 1-vs-Grade 3 |
1.686040E-01 |
| Grade 1-vs-Grade 4 |
3.282400E-02 |
| Grade 2-vs-Grade 3 |
5.244600E-04 |
| Grade 2-vs-Grade 4 |
2.20949999999442E-05 |
| Grade 3-vs-Grade 4 |
9.607800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.144220E-02 |
| Normal-vs-ccB subtype |
1.141400E-01 |
| ccA subtype-vs-ccB subtype |
6.477800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.00009999999917E-05 |
| Normal-vs-N1 |
1.772960E-01 |
| N0-vs-N1 |
6.785200E-01 |
|
|
